| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |